Here are the 424B prospectus supplements from Incannex Healthcare Limited (IXHL) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow IXHL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IXHL filings page.
Incannex Healthcare Inc. is offering 1,997,285 shares of common stock together with accompanying Common Warrants to purchase up to 2,000,000 shares of common stock at a combined unit price of $5.00 per share and accompanying warrant. The offering also includes Pre-Funded Warrants to purchase up to 2,715 shares for eligible investors subject to ownership caps.
The Common Warrants have an exercise price of $6.50 and a five-year term; Pre-Funded Warrants are exercisable for $0.0001 per share. The company estimates net proceeds of approximately $8.9 million, intending to use proceeds for working capital, research and development, and clinical trial expenses. The placement agent is Curvature Securities LLC and delivery is expected on or about March 13, 2026.